Results 131 to 140 of about 13,363 (168)

[Expert consensus on the clinical application of gut microbiota transplant therapy in chronic liver disease (version 2025)]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Liver Related Digestive Diseases Group, Chinese Society of Hepatology, Chinese Medical Association.   +2 more
europepmc   +1 more source

[Research progress on clinical characteristics and pathological mechanisms of lean metabolic-associated fatty liver disease]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
He N, Zhang XY, Lyu BB, Wang ZY, Hao S, Zhang FN.   +5 more
europepmc   +1 more source

[Exploring the relationship between alcohol intake and all-cause mortality in participants with MASLD and MetALD: a study based on NHANES III data]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Jia LY, Rui FJ, Wu XY, Zhou SS, Chen YJ, Wu C, Shi JP, Wu WH, Li J.   +8 more
europepmc   +1 more source

[Cajanonic acid A derivative XJ-60 improves liver fibrosis in mice with non-alcoholic fatty liver disease by inhibiting the SP1/TGF-β/Smad3 signaling axis]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Geng Z, Hu L, Dai Y, Luo R, Xu T, Liao X, Yuan Z, Wang J, Xiao Y.   +8 more
europepmc   +1 more source

[Real-time or dynamic non-invasive liver fibrosis testing for evaluating clinical prognoses and predicting chronic liver disease]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Zhao XY, Sun YM, Gao YK, Lu ZZ, Huang C, Kong YY, Jia JD, You H.   +7 more
europepmc   +1 more source

[Guideline for diagnosis and management of metabolic dysfunction-associated fatty liver disease in primary care (2025)]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Chronic Disease Management Branch of China Medical Biotechnology Association, Chinese Research Hospital Society (Integrative Chinese and Western Medicine), Chinese Society of General Practice, Chinese Medical Association, Expert Group of Guideline for Diagnosis and Management of Metabolic Dysfunction-Associated Fatty Liver Disease in Primary Care.   +4 more
europepmc   +1 more source